PNPLA3 and metabolic dysfunction-associated steatohepatitis: Single-nucleotide polymorphisms involving PNPLA3 (patatin-like phospholipase domain-containing protein 3) and TM6SF2 (transmembrane 6 superfamily member 2) are the most well-recognized genetic mutations involved in the development of NASH.